NCT02669849: A reported trial by Vertex Pharmaceuticals Incorporated
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02669849 |
|---|---|
| Title | A Phase 2b/3, Double-blind, Randomized, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of VX-210 in Subjects With Acute Traumatic Cervical Spinal Cord Injury |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | July 31, 2016 |
| Completion date | Nov. 30, 2018 |
| Required reporting date | Nov. 30, 2019, midnight |
| Actual reporting date | Nov. 29, 2019 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |